Google+ Badge

Tuesday, January 28, 2014

2/28/14 Health News: Live Stock Antibiotics are High Risk - FDA bans Product from Indian Plant - Repair Damage from Heart Attacks - Gene Therapy Cures Blindness

NRDC ANALYSIS OF FDA DOCUMENTS FINDS LIVESTOCK ANTIBIOTICS “HIGH RISK” TO HUMANS
According to a safety review conducted by the U.S. Food and Drug Administration, penicillin and tetracycline antibiotic feed additives approved for “nontherapeutic use” do not meet the agency’s current safety standards. In a Natural Resources Defense Council (NRDC) report released today, previously undisclosed FDA documents reveal that none of the 30 products reviewed between 2001... Continue Reading

India's Ranbaxy hit by FDA product ban at 4th Indian plant

Indian drugmaker Ranbaxy Laboratories Ltd faces long delays and high costs in launching big-selling generic drugs in the United States after products from a fourth plant were banned from entering its main market due to manufacturing violations. Continue Reading
New Therapy Tries to Repair Damage in Heart Attacks
In a heart attack, the initial harm is often compounded by a person's immune system, which rushes "soldiers" to the heart to fight what it thinks are invaders. An immune system overreaction also causes much of the trouble in irritable bowel syndrome, multiple sclerosis and West Nile Virus. "The immune system does a significant amount of damage while it's trying to protect us," : Continue Reading
Gene Therapy 'Could Be Used to Treat Blindness'

Surgeons in Oxford have used a gene therapy technique to improve the vision of six patients who would otherwise have gone blind. The operation involved inserting a gene into the eye, a treatment that revived light-detecting cells. The doctors involved believe that the treatment could in time be used to treat common forms of blindness..Continue Reading

No comments:

Post a Comment